Идёт набор NCT07102615

Intracervical Vasopressin

Фаза IV С лечением Retained Products of Conception

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают: В протоколе указаны: Intracervical injection of Vasopressin, Intracervical Injection of saline.
Кому может быть актуально: Состояния в реестре: Retained Products of Conception. Базовые параметры: 18 лет — 51 лет · Женщины.
Что важно проверить: Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится: США
Следующий шаг: Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →

Не всё понятно в терминах? Прочитайте наш гид для пациентов →

Официальное название

Intracervical Vasopressin for Completion of Hysteroscopic Removal of Retained Products of Conception

Обзор

This randomized study looks at whether using a medicine injected into the cervix of the uterus (intracervical), called vasopressin, helps to achieve better removal of retained products of conception (RPOC). RPOC means that after a pregnancy has ended (through miscarriage, abortion, or delivery), some parts of the pregnancy tissue, usually from the placenta or fetus, have stayed in the uterus. A hysteroscopic removal of RPOC is one type of treatment. This is a surgical procedure where a doctor uses a small camera attached to a thin tube (called a hysteroscope) to look inside the uterus. The main goal of the study is : • To add to the existing research through this study to see if the injection of intracervical vasopressin leads to improved completion rates of hysteroscopic management of RPOC. Participants will: • would be randomized to receive either vasopressin intracervical injection or a placebo injection (non-active saline) during your procedure. Information from the procedure will be collected from the participant's medical record.

Подробное описание

This double-blinded randomized control trial is designed to evaluate if intraoperative injection of intracervical vasopressin into the cervix will allow for completion of hysteroscopic removal of retained products of conception. This will be measured by surgical completion comparing patients who received intracervical vasopressin and those receiving placebo. Surgical completion is defined by completing the procedure without having to convert to suction of tissue due to bleeding or poor visualization. Secondary outcome measures include intraoperative bleeding, operative time, fluid deficit, and deficit volume.

Вмешательства

Препарат Intracervical injection of Vasopressin
Intracervical injection of Vasopressin
Препарат Intracervical Injection of saline
Intracervical Injection of saline

Первичные конечные точки

Completion of procedure hysteroscopically [Срок оценки: from start of procedure to end of procedure]

Вторичные конечные точки (3)

Intraoperative Bleeding [Срок оценки: from start of procedure to end of procedure]
Operative time [Срок оценки: time from insertion of hysteroscope to procedure completion]
fluid deficit volume [Срок оценки: from start of procedure to end of procedure]

Критерии участия

Критерии включения

Women
Aged 18-51
Undergoing surgical management for retained products of conception, postpartum retained products of conception or 1st trimester missed or incomplete abortion